A detailed history of Deutsche Bank Ag\ transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 300,591 shares of ALDX stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300,591
Previous 300,352 0.08%
Holding current value
$1.56 Million
Previous $994,000 62.98%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.19 - $6.32 $762 - $1,510
239 Added 0.08%
300,591 $1.62 Million
Q2 2024

Aug 14, 2024

BUY
$3.25 - $4.72 $25,886 - $37,594
7,965 Added 2.72%
300,352 $994,000
Q1 2024

May 15, 2024

SELL
$2.77 - $4.22 $13,985 - $21,306
-5,049 Reduced 1.7%
292,387 $956,000
Q4 2023

Feb 14, 2024

BUY
$1.47 - $6.06 $3,911 - $16,125
2,661 Added 0.9%
297,436 $1.04 Million
Q3 2023

Nov 09, 2023

BUY
$6.11 - $8.16 $39,531 - $52,795
6,470 Added 2.24%
294,775 $1.97 Million
Q2 2023

Aug 14, 2023

BUY
$7.11 - $11.89 $456,824 - $763,944
64,251 Added 28.68%
288,305 $2.42 Million
Q1 2023

May 15, 2023

SELL
$5.77 - $9.93 $31,157 - $53,622
-5,400 Reduced 2.35%
224,054 $2.22 Million
Q2 2022

Aug 11, 2022

SELL
$2.43 - $4.85 $161,286 - $321,909
-66,373 Reduced 22.44%
229,454 $916,000
Q1 2022

May 13, 2022

BUY
$3.25 - $5.17 $113,265 - $180,179
34,851 Added 13.35%
295,827 $1.32 Million
Q4 2021

Feb 11, 2022

BUY
$3.5 - $9.63 $5,432 - $14,945
1,552 Added 0.6%
260,976 $1.04 Million
Q3 2021

Nov 04, 2021

SELL
$7.94 - $11.31 $7,146 - $10,179
-900 Reduced 0.35%
259,424 $2.28 Million
Q2 2021

Aug 11, 2021

SELL
$10.44 - $14.85 $410,385 - $583,738
-39,309 Reduced 13.12%
260,324 $2.95 Million
Q4 2020

Feb 16, 2021

BUY
$6.31 - $8.13 $753,470 - $970,795
119,409 Added 66.26%
299,633 $2.06 Million
Q3 2020

Nov 12, 2020

BUY
$4.0 - $7.53 $402,668 - $758,022
100,667 Added 126.53%
180,224 $1.34 Million
Q2 2020

Aug 13, 2020

BUY
$1.97 - $5.05 $124,307 - $318,655
63,100 Added 383.42%
79,557 $332,000
Q1 2020

May 14, 2020

SELL
$1.62 - $6.4 $28,260 - $111,648
-17,445 Reduced 51.46%
16,457 $40,000
Q4 2019

Feb 14, 2020

BUY
$4.73 - $7.98 $88,649 - $149,561
18,742 Added 123.63%
33,902 $195,000
Q3 2019

Nov 14, 2019

SELL
$4.41 - $6.12 $51,694 - $71,738
-11,722 Reduced 43.61%
15,160 $79,000
Q2 2019

Aug 14, 2019

SELL
$6.0 - $9.0 $52,596 - $78,894
-8,766 Reduced 24.59%
26,882 $160,000
Q1 2019

May 15, 2019

SELL
$7.14 - $9.85 $28,631 - $39,498
-4,010 Reduced 10.11%
35,648 $321,000
Q4 2018

Feb 14, 2019

BUY
$7.26 - $13.29 $9,285 - $16,997
1,279 Added 3.33%
39,658 $328,000
Q3 2018

Dec 21, 2021

BUY
$6.8 - $14.35 $30,423 - $64,201
4,474 Added 13.2%
38,379 $530,000
Q3 2018

Nov 14, 2018

BUY
$6.8 - $14.35 $22,773 - $48,058
3,349 Added 10.96%
33,905 $466,000
Q2 2018

Apr 21, 2020

BUY
$6.95 - $9.18 $35,917 - $47,442
5,168 Added 20.36%
30,556 $243,000
Q2 2018

Aug 14, 2018

BUY
$6.95 - $9.18 $176,446 - $233,061
25,388 New
25,388 $201,000
Q1 2018

May 15, 2018

SELL
$6.55 - $8.9 $11,135 - $15,130
-1,700 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$5.7 - $7.75 $35,910 - $48,825
-6,300 Reduced 78.75%
1,700 $11,000
Q3 2017

Nov 14, 2017

BUY
$3.9 - $10.8 $31,200 - $86,400
8,000
8,000 $57,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $302M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.